🔎 Trials Near Me

Home › Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder clinical trials recruiting in the U.S.

68 studies for Attention Deficit Hyperactivity Disorder are recruiting participants at sites across the United States.

Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.

Cities with the most studies

By state

Recently updated studies

Developing Brain, Impulsivity and Compulsivity

RecruitingObservational study
Ages 6 to 80 · All sexes · Updated Sep 25, 2026 · NCT04631042

Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder

Recruiting
Ages 18 to 55 · All sexes · Updated Sep 21, 2026 · NCT07793045

Fidgeting and Attentional and Emotional Regulation in ADHD

Recruiting
Ages 18 to 30 · All sexes · Updated Sep 15, 2026 · NCT04526600

Treating Young Children With Attention Deficit Hyperactivity Disorder

RecruitingPhase 4
Ages 3 to 5 · All sexes · Updated Sep 14, 2026 · NCT07300956

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

RecruitingPhase 1
Ages 8 to 17 · All sexes · Updated Sep 9, 2026 · NCT07226219

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

RecruitingObservational study
Ages 18 to 100 · Women · Updated Sep 8, 2026 · NCT07540585

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879

Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD

Recruiting
Ages 4 to 8 · All sexes · Updated Aug 25, 2026 · NCT07784348

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404

Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Aug 19, 2026 · NCT05776056

Smartphone-based Intervention for Young Adults With ADHD

Recruiting
Ages 18 to 25 · All sexes · Updated Aug 18, 2026 · NCT07654205

Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study

Recruiting
Ages 13 to 17 · All sexes · Updated Aug 17, 2026 · NCT07684417

Virtual Reality Attention Management

Recruiting
Ages 8 to 12 · All sexes · Updated Aug 7, 2026 · NCT03221244

Medication Treatment of ADHD in Pediatric Epilepsy

RecruitingPhase 4
Ages 6 to 17 · All sexes · Updated Jul 29, 2026 · NCT07594652

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Recruiting
Ages 8 to 12 · All sexes · Updated Jul 16, 2026 · NCT06847165

Atomoxetine and Executive Function in PTSD

RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 7, 2026 · NCT06573970

Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD

Recruiting
Ages 7 to 11 · All sexes · Updated Jun 30, 2026 · NCT06180681

Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation

RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT05802680

Effects of Transcranial Photobiomodulation in ADHD

Recruiting
Ages 18 to 44 · All sexes · Updated Jun 22, 2026 · NCT07203092

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.